Gilead Provides Update on Phase 3 EVOKE-01 Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| Gilead Sciences (NASDAQ: GILD) | Delayed: 156.19 -1.18 (0.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $157.37 | 52 Week High | $108.63 | |||
| Open | $157.32 | 52 Week Low | $71.39 | |||
| Day High | $157.58 | P/E | 86.29 | |||
| Day Low | $155.62 | EPS | $1.81 | |||
| Volume | 7,775,707 | |||||
